Clinical Trial Update: Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products [NA]

View source ↗

Summary

A completed ClinicalTrials.gov study evaluated urinary Proanthocyanidin-A2 as a biomarker of adherence to cranberry product intake, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Snippet

Sponsor: Tufts University | Conditions: Urinary Tract Infection | NA | Status: COMPLETED | Results posted: 2014-12-15